Subscribe to the newsletter

Publications

Latest publications

Load previous publications
  • janvier 1, 2010

    From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

    Frémin C, Meloche S
    J Hematol Oncol 2010-01-01 ;3:8

  • janvier 1, 2010

    [Hopes and challenges in biomedical research].

    Bouvier M, Chneiweiss H
    Med Sci (Paris) 2010-01-01 ;26( 1 ):3-4

  • janvier 1, 2010

    Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.

    Foster KG, Acosta-Jaquez HA, Romeo Y, Ekim B, Soliman GA, Carriere A, Roux PP, Ballif BA, Fingar DC
    J. Biol. Chem. 2010-01-01 ;285( 1 ):80-94

  • décembre 1, 2009

    Recurated protein interaction datasets.

    Salwinski L, Licata L, Winter A, Thorneycroft D, Khadake J, Ceol A, Aryamontri AC, Oughtred R, Livstone M, Boucher L, Botstein D, Dolinski K, Berardini T, Huala E, Tyers M, Eisenberg D, Cesareni G, Hermjakob H
    Nat. Methods 2009-12-01 ;6( 12 ):860-1

  • décembre 1, 2009

    Life and death decisions.

    Amon A, Tyers M
    Curr. Opin. Cell Biol. 2009-12-01 ;21( 6 ):767-70

  • décembre 1, 2009

    Two fundamentally distinct PCNA interaction peptides contribute to chromatin assembly factor 1 function.

    Rolef Ben-Shahar T, Castillo AG, Osborne MJ, Borden K, Kornblatt J, Verreault A
    Mol. Cell. Biol. 2009-12-01 ;29( 24 ):6353-65

  • décembre 1, 2009

    Kinetic characterization of recombinant mouse retinal dehydrogenase types 3 and 4 for retinal substrates.

    Sima A, Parisotto M, Mader S, Bhat PV
    Biochim. Biophys. Acta 2009-12-01 ;1790( 12 ):1660-4

  • décembre 1, 2009

    A mechanism of nucleocytoplasmic trafficking for the homeodomain protein PRH.

    Ploski JE, Topisirovic I, Park KW, Borden K, Radu A
    Mol. Cell. Biochem. 2009-12-01 ;332( 1-2 ):173-81

Load more publications